Baxter teams with Cell Therapeutics on cancer drug

As part of a push to expand its portfolio of oncology drugs, Baxter International Inc. has signed a worldwide licensing agreement with Cell Therapeutics Inc...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.